Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06315205
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-03-11
Brief Title:
Evaluation of the Pharmacokinetics Safety and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Rovi Pharmaceuticals Laboratories
Organization Data
Organization:
Rovi Pharmaceuticals Laboratories
Class:
INDUSTRY
Study ID:
ROV-LEBE-2023-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rovi Pharmaceuticals Laboratories
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None